Published in J Am Acad Dermatol on February 01, 2005
Mutational status of naevus-associated melanomas. Br J Dermatol (2015) 2.68
Giant congenital melanocytic nevus. An Bras Dermatol (2014) 1.32
Malignant melanoma in the 21st century: the emerging molecular landscape. Mayo Clin Proc (2008) 1.13
Giant congenital melanocytic nevus with developmental dysplasia of bilateral hip: a rare association. Indian J Dermatol (2013) 1.03
Multilineage somatic activating mutations in HRAS and NRAS cause mosaic cutaneous and skeletal lesions, elevated FGF23 and hypophosphatemia. Hum Mol Genet (2013) 0.96
Vacations to waterside locations result in nevus development in Colorado children. Cancer Epidemiol Biomarkers Prev (2009) 0.95
Molecular targeted therapies in metastatic melanoma. Pharmgenomics Pers Med (2013) 0.87
Autologous skin reconstruction by combining epidermis and acellular dermal matrix tissue derived from the skin of giant congenital melanocytic nevi. J Artif Organs (2013) 0.86
Pathology of eyelid tumors. Indian J Ophthalmol (2016) 0.84
Staged Surgery with Total Excision and Lamellar Reconstructive for Medium-sized Divided Nevus of the Eyelids. Plast Reconstr Surg Glob Open (2015) 0.81
The risk of cutaneous melanoma in melanocytic nevi. An Bras Dermatol (2013) 0.81
Skingineering I: engineering porcine dermo-epidermal skin analogues for autologous transplantation in a large animal model. Pediatr Surg Int (2011) 0.79
The incidence and position of melanocytic nevi for the purposes of forensic image comparison. Int J Legal Med (2013) 0.79
Skin cancer of the head and neck. Semin Plast Surg (2010) 0.79
An Exploratory Clinical Trial of a Novel Treatment for Giant Congenital Melanocytic Nevi Combining Inactivated Autologous Nevus Tissue by High Hydrostatic Pressure and a Cultured Epidermal Autograft: Study Protocol. JMIR Res Protoc (2016) 0.75
Dermoscopic Features of Small, Medium, and Large-Sized Congenital Melanocytic Nevi. Ann Dermatol (2017) 0.75
A Novel Reconstructive Procedure for the Divided Nevus of the Eyelids Using a Tissue Expander. Plast Reconstr Surg Glob Open (2016) 0.75
Report of a malignant melanoma arising in a small congenital nevus in a 3-year-old child. J Indian Assoc Pediatr Surg (2013) 0.75
Congenital melanocytic nevus is a disease with two clinicopathologic forms of presentation. J Am Acad Dermatol (2007) 0.75
The Alteration of the Epidermal Basement Membrane Complex of Human Nevus Tissue and Keratinocyte Attachment after High Hydrostatic Pressurization. Biomed Res Int (2016) 0.75
Congenital Melanocytic Nevi. Eplasty (2016) 0.75
Intense Pulsed Light Alone and in Combination with Erbium Yttrium-Aluminum-Garnet Laser on Small-to-Medium Sized Congenital Melanocytic Nevi: Single Center Experience Based on Retrospective Chart Review. Ann Dermatol (2017) 0.75
Congenital melanocytic nevus of upper eyelid. J Cutan Aesthet Surg (2011) 0.75
A prospective study of patients with large congenital melanocytic nevi and the risk of melanoma. An Bras Dermatol (2017) 0.75
Final version of 2009 AJCC melanoma staging and classification. J Clin Oncol (2009) 23.08
WHO-EORTC classification for cutaneous lymphomas. Blood (2005) 12.14
Management of cutaneous melanoma. N Engl J Med (2004) 9.52
Melanoma. N Engl J Med (2006) 8.80
Identification of cells initiating human melanomas. Nature (2008) 8.28
Biologic activity of cytotoxic T lymphocyte-associated antigen 4 antibody blockade in previously vaccinated metastatic melanoma and ovarian carcinoma patients. Proc Natl Acad Sci U S A (2003) 5.49
Comparative oncogenomics identifies NEDD9 as a melanoma metastasis gene. Cell (2006) 4.68
Immunologic and clinical effects of antibody blockade of cytotoxic T lymphocyte-associated antigen 4 in previously vaccinated cancer patients. Proc Natl Acad Sci U S A (2008) 4.43
Loss of 5-hydroxymethylcytosine is an epigenetic hallmark of melanoma. Cell (2012) 4.04
Variability in nomenclature used for nevi with architectural disorder and cytologic atypia (microscopically dysplastic nevi) by dermatologists and dermatopathologists. J Cutan Pathol (2004) 3.43
Pathologic nodal evaluation improves prognostic accuracy in Merkel cell carcinoma: analysis of 5823 cases as the basis of the first consensus staging system. J Am Acad Dermatol (2010) 2.83
Tumor lymphangiogenesis: a novel prognostic indicator for cutaneous melanoma metastasis and survival. Am J Pathol (2003) 2.81
De novo intraepidermal epithelioid melanocytic dysplasia as a marker of the atypical mole phenotype -- a clinical and pathological study of 75 patients. J Cutan Pathol (2005) 2.38
An ultraviolet-radiation-independent pathway to melanoma carcinogenesis in the red hair/fair skin background. Nature (2012) 2.35
Multivariate analysis of prognostic factors among 2,313 patients with stage III melanoma: comparison of nodal micrometastases versus macrometastases. J Clin Oncol (2010) 2.30
Whole-slide imaging digital pathology as a platform for teleconsultation: a pilot study using paired subspecialist correlations. Arch Pathol Lab Med (2009) 2.30
Pigmented epithelioid melanocytoma: a low-grade melanocytic tumor with metastatic potential indistinguishable from animal-type melanoma and epithelioid blue nevus. Am J Surg Pathol (2004) 2.29
Pyoderma gangrenosum: a review. J Cutan Pathol (2003) 2.23
Tumor lymphangiogenesis predicts melanoma metastasis to sentinel lymph nodes. Mod Pathol (2005) 2.12
Broad range of adverse cutaneous eruptions in patients on TNF-alpha antagonists. J Cutan Pathol (2012) 2.08
Case records of the Massachusetts General Hospital. Case 23-2014. A 41-year-old man with fevers, rash, pancytopenia, and abnormal liver function. N Engl J Med (2014) 2.00
Integrative genome comparison of primary and metastatic melanomas. PLoS One (2010) 1.97
An oncogenic role for ETV1 in melanoma. Cancer Res (2010) 1.94
Unusual variants of malignant melanoma. Mod Pathol (2006) 1.93
Melanoma of unknown primary: experience at Massachusetts General Hospital and Dana-Farber Cancer Institute. Melanoma Res (2005) 1.87
Prognostic significance of mitotic rate in localized primary cutaneous melanoma: an analysis of patients in the multi-institutional American Joint Committee on Cancer melanoma staging database. J Clin Oncol (2011) 1.78
Germline BAP1 inactivation is preferentially associated with metastatic ocular melanoma and cutaneous-ocular melanoma families. PLoS One (2012) 1.76
Guidelines of care for the management of primary cutaneous melanoma. American Academy of Dermatology. J Am Acad Dermatol (2011) 1.75
Focus on TILs: prognostic significance of tumor infiltrating lymphocytes in human melanoma. Cancer Immun (2009) 1.74
Cutaneous vasculitis: a review. J Cutan Pathol (2003) 1.74
Biology of desmoplastic melanoma: a case-control comparison with other melanomas. J Clin Oncol (2005) 1.71
State of the art, nomenclature, and points of consensus and controversy concerning benign melanocytic lesions: outcome of an international workshop. Adv Anat Pathol (2010) 1.68
EANM-EORTC general recommendations for sentinel node diagnostics in melanoma. Eur J Nucl Med Mol Imaging (2009) 1.68
Pigmented epithelioid melanocytoma: report of first Japanese cases previously diagnosed as cellular blue nevus. J Cutan Pathol (2009) 1.48
Genetic and morphologic features for melanoma classification. Pigment Cell Melanoma Res (2010) 1.47
Warfarin-induced skin necrosis. J Am Acad Dermatol (2009) 1.44
Method of biopsy and incidence of positive margins in primary melanoma. Ann Surg Oncol (2007) 1.44
Photodynamic therapy for cutaneous proliferative vascular tumors in a mouse model. J Invest Dermatol (2003) 1.42
Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 7-2004. A 48-year-old woman with multiple pigmented lesions and a personal and family history of melanoma. N Engl J Med (2004) 1.38
Biologic activity of irradiated, autologous, GM-CSF-secreting leukemia cell vaccines early after allogeneic stem cell transplantation. Proc Natl Acad Sci U S A (2009) 1.34
Current concepts of metastasis in melanoma. Expert Rev Dermatol (2008) 1.34
MERTK receptor tyrosine kinase is a therapeutic target in melanoma. J Clin Invest (2013) 1.34
PTEN expression in normal skin, acquired melanocytic nevi, and cutaneous melanoma. J Am Acad Dermatol (2003) 1.33
HIF1α and HIF2α independently activate SRC to promote melanoma metastases. J Clin Invest (2013) 1.32
Milk fat globule EGF-8 promotes melanoma progression through coordinated Akt and twist signaling in the tumor microenvironment. Cancer Res (2008) 1.29
The diagnostic performance of expert dermoscopists vs a computer-vision system on small-diameter melanomas. Arch Dermatol (2008) 1.28
Malignant adnexal neoplasms. Mod Pathol (2006) 1.26
Skin cancer prevention and detection practices among siblings of patients with melanoma. J Am Acad Dermatol (2003) 1.22
Long-term blood vessel removal with combined laser and topical rapamycin antiangiogenic therapy: implications for effective port wine stain treatment. Lasers Surg Med (2010) 1.21
SOX2 contributes to melanoma cell invasion. Lab Invest (2011) 1.21
Melanoma epidemic: an analysis of six decades of data from the Connecticut Tumor Registry. J Clin Oncol (2013) 1.19
Melanoma in the young: differences and similarities with adult melanoma: a case-matched controlled analysis. Cancer (2007) 1.18
Isolation, characterization, and in vitro propagation of infantile hemangioma stem cells and an in vivo mouse model. J Hematol Oncol (2011) 1.18
Pilomatrix carcinomas contain mutations in CTNNB1, the gene encoding beta-catenin. J Cutan Pathol (2005) 1.17
Cytotoxic/natural killer cell cutaneous lymphomas. Report of EORTC Cutaneous Lymphoma Task Force Workshop. Cancer (2003) 1.15
Novel genetic mutations in a sporadic port-wine stain. JAMA Dermatol (2014) 1.12
Proliferative nodules arising within congenital melanocytic nevi: a histologic, immunohistochemical, and molecular analyses of 43 cases. Am J Surg Pathol (2011) 1.11
MicroRNA-mediated loss of ADAR1 in metastatic melanoma promotes tumor growth. J Clin Invest (2013) 1.11
Infantile hemangiomas are arrested in an early developmental vascular differentiation state. Mod Pathol (2004) 1.10
Utility of lesion diameter in the clinical diagnosis of cutaneous melanoma. Arch Dermatol (2008) 1.10
Importance of glycolysis and oxidative phosphorylation in advanced melanoma. Mol Cancer (2012) 1.10
Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 23-2003. A 79-year-old woman with gastric lymphoma and erosive mucosal and cutaneous lesions. N Engl J Med (2003) 1.10
Vascular tumors of infancy and childhood: beyond capillary hemangioma. Cardiovasc Pathol (2006) 1.09
Estimating CDKN2A carrier probability and personalizing cancer risk assessments in hereditary melanoma using MelaPRO. Cancer Res (2010) 1.08
Congenital and infantile melanoma: review of the literature and report of an uncommon variant, pigment-synthesizing melanoma. J Am Acad Dermatol (2002) 1.08
Drug-induced linear IgA bullous dermatosis. J Dermatol (2005) 1.07
A new American Joint Committee on Cancer staging system for cutaneous squamous cell carcinoma: creation and rationale for inclusion of tumor (T) characteristics. J Am Acad Dermatol (2011) 1.06
Atypical and malignant hidradenomas: a histological and immunohistochemical study. Mod Pathol (2009) 1.06
De novo intraepidermal epithelioid melanocytic dysplasia: an emerging entity. J Cutan Pathol (2009) 1.06
A randomized trial to improve early detection and prevention practices among siblings of melanoma patients. Cancer (2006) 1.05
Melanoma biomarker expression in melanocytic tumor progression: a tissue microarray study. J Cutan Pathol (2010) 1.05
Constitutive aberrant endogenous interleukin-1 facilitates inflammation and growth in human melanoma. Mol Cancer Res (2011) 1.04
Expression of prox1, lymphatic endothelial nuclear transcription factor, in Kaposiform hemangioendothelioma and tufted angioma. Am J Surg Pathol (2010) 1.04
The nonrandom distribution of facial hemangiomas. Arch Dermatol (2003) 1.03
Melanoma incidence trends. Dermatol Clin (2002) 1.03
Pigmented epithelioid melanocytoma: favorable outcome after 5-year follow-up. Am J Surg Pathol (2009) 1.03
AJCC melanoma staging update: impact on dermatopathology practice and patient management. J Cutan Pathol (2011) 1.02
Recurrent nevus phenomenon: a clinicopathologic study of 357 cases and histologic comparison with melanoma with regression. Mod Pathol (2009) 1.02
Markers and tissue resources for melanoma: meeting report. Cancer Res (2006) 1.01
Apocrine-eccrine carcinomas: molecular and immunohistochemical analyses. PLoS One (2012) 1.01
Prox-1 promotes invasion of kaposiform hemangioendotheliomas. J Invest Dermatol (2008) 1.01
The first 15 years of the American Academy of Dermatology skin cancer screening programs: 1985-1999. J Am Acad Dermatol (2003) 1.00
Molecular mechanisms of metastasis. Cancer Metastasis Rev (2006) 1.00
Non-thermal, pulsed electric field cell ablation: A novel tool for regenerative medicine and scarless skin regeneration. Technology (Singap World Sci) (2013) 0.99
Histomorphologic assessment and interobserver diagnostic reproducibility of atypical spitzoid melanocytic neoplasms with long-term follow-up. Am J Surg Pathol (2014) 0.99
Immunoglobulin-A--associated small-vessel vasculitis: a 10-year experience at the Massachusetts General Hospital. J Am Acad Dermatol (2011) 0.99
Subcutaneous Sweet syndrome in the setting of myeloid disorders: a case series and review of the literature. J Am Acad Dermatol (2013) 0.98
Slug expression during melanoma progression. Am J Pathol (2012) 0.97
Case records of the Massachusetts General Hospital. Weekly clinicopathological exercises. Case 13-2004. A newborn girl with a large cutaneous lesion, thrombocytopenia, and anemia. N Engl J Med (2004) 0.96
Loss of expression of protein kinase a regulatory subunit 1alpha in pigmented epithelioid melanocytoma but not in melanoma or other melanocytic lesions. Am J Surg Pathol (2007) 0.96
Bullous reactions to bedbug bites reflect cutaneous vasculitis. Am J Med (2012) 0.96